Literature DB >> 1466843

Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-alpha.

R Banerjee1, K Sperber, T Pizzella, L Mayer.   

Abstract

OBJECTIVE: To evaluate the role of liver cells in and the effect of tumor necrosis factor-alpha (TNF-alpha) on HIV-1 replication.
METHODS: Human hepatoblastoma HepG2 cells were infected with various strains of HIV-1 and the effect of TNF-alpha treatment, either before or after infection, was monitored by p24 antigen assays. Northern blot analysis and gel retardation assays were performed to determine the expression of CD4 and HIV-1 trans-acting region (TAR)-binding proteins in these cells, respectively.
RESULTS: HepG2 cells are CD4+ and support active HIV-1 replication, producing infectious virions, as measured by both p24 production and ability to infect T-cell lines with the virus produced by HepG2 cells. In contrast to the stimulatory effect of TNF-alpha on HIV-1 replication in T-cells and monocytes, up to 200 U/ml TNF-alpha treatment, at various times, either before or after HIV-1 infection, substantially inhibited p24 antigen production in HepG2 cells without causing any remarkable cytotoxicity. Gel-retardation assay revealed enhancement of a DNA-binding protein in TNF-alpha-treated HepG2 cells that binds to a specific sequence of the HIV-1 TAR, compared with the untreated control.
CONCLUSIONS: These results indicate the importance of cellular factor(s) in HIV-1 infection and suggest that cytokines in different tissues can induce opposite effects. TAR-binding protein may act as an inhibitory factor for HIV-1 replication in the HepG2 cell line.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466843     DOI: 10.1097/00002030-199210000-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  12 in total

1.  HIV variability in the liver and evidence of possible compartmentalization.

Authors:  Jason T Blackard; Gang Ma; Christina M Martin; Susan D Rouster; M Tarek Shata; Kenneth E Sherman
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-04       Impact factor: 2.205

2.  HIV-1 coinfection and morphine coexposure severely dysregulate hepatitis C virus-induced hepatic proinflammatory cytokine release and free radical production: increased pathogenesis coincides with uncoordinated host defenses.

Authors:  Nazira El-Hage; Seth M Dever; Sylvia Fitting; Tasrif Ahmed; Kurt F Hauser
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

3.  HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women.

Authors:  Jason T Blackard; Jeffrey A Welge; Lynn E Taylor; Kenneth H Mayer; Robert S Klein; David D Celentano; Denise J Jamieson; Lytt Gardner; Kenneth E Sherman
Journal:  Clin Infect Dis       Date:  2011-01-19       Impact factor: 9.079

4.  Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.

Authors:  Bill G Kapogiannis; Erin Leister; George K Siberry; Russell B Van Dyke; Bret Rudy; Patricia Flynn; Paige L Williams
Journal:  AIDS       Date:  2016-03-27       Impact factor: 4.177

Review 5.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

6.  Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.

Authors:  J Judy Chang; Sunee Sirivichayakul; Anchalee Avihingsanon; Alex J V Thompson; Peter Revill; David Iser; John Slavin; Supranee Buranapraditkun; Pip Marks; Gail Matthews; David A Cooper; Stephen J Kent; Paul U Cameron; Joe Sasadeusz; Paul Desmond; Stephen Locarnini; Gregory J Dore; Kiat Ruxrungtham; Sharon R Lewin
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

7.  Low-level HIV infection of hepatocytes.

Authors:  Ling Kong; Walter Cardona Maya; Maria E Moreno-Fernandez; Gang Ma; Mohamed T Shata; Kenneth E Sherman; Claire Chougnet; Jason T Blackard
Journal:  Virol J       Date:  2012-08-09       Impact factor: 4.099

8.  Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.

Authors:  Amanda Whitmill; Seongcheol Kim; Vivian Rojas; Fahad Gulraiz; Kazi Afreen; Mamta Jain; Meharvan Singh; In-Woo Park
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

Review 9.  Liver as a target of human immunodeficiency virus infection.

Authors:  Murali Ganesan; Larisa Y Poluektova; Kusum K Kharbanda; Natalia A Osna
Journal:  World J Gastroenterol       Date:  2018-11-14       Impact factor: 5.742

10.  Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation.

Authors:  Kenji Shibuta; Masaki Mori; Katsuhiro Shimoda; Hiroshi Inoue; Prasenjit Mitra; Graham F Barnard
Journal:  Jpn J Cancer Res       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.